Our Portfolio

Our Strategy

Before Clinical Proof of Concept

We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data.


We believe there lies opportunity in multi-product platforms. Complex questions of growth, strategy and value creation are front and center, and offer asymmetric upside.

Our Values

Originate Conviction
Act Decisively
Be Collaborative
Stay Nimble

Patients are waiting. Biopharma’s essence is delivering innovative medicines to patients with major unmet needs. Management, scientists, clinical investigators, and investors all together strive towards that shared goal. Today, the biotech renaissance is in full swing. This is the time to invest. The global convergence of biological and chemical insights, life science technology, data analytics, talent and capital is unprecedented.



For general inquiries please contact us at: info@ascentacap.com